Chief Executive Officer since March 2021
Erik Kinnman is a physician, Ph.D. , and associate professor at Karolinska Institutet. He has a specialist education in neurology and pain management, as well as has an Executive MBA from the Stockholm School of Economics.
Erik has 25 years of experience from senior positions in Life Science, of which in recent years as CEO of Abliva AB (formerly Neurovive), a biotechnology company listed on Nasdaq Stockholm’s main list. Furthermore, Erik Kinnman has held senior positions at AstraZeneca and SOBI, among others, and has been active as a financial analyst at Danske Bank.
NUMBER OF SHARES AND WARRANTS (AS OF 1ST OF MARCH 2021)